Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden
· Delayed Price · Currency is SEK 9.45
-0.04 (-0.42%)
Jun 26, 2025, 3:12 PM CET
Diamyd Medical AB Income Statement
Financials in millions SEK. Fiscal year is September - August.
Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | 2015 - 2019 |
| 0.13 | 0.13 | 0.55 | 0.45 | 0.25 | 0.34 | Upgrade
| |
Revenue Growth (YoY) | -30.64% | -76.19% | 20.26% | 79.45% | -25.81% | -78.25% | Upgrade
|
Cost of Revenue | 3.95 | 3.71 | 3.63 | 4.4 | 2.5 | 4.49 | Upgrade
|
Gross Profit | -3.82 | -3.58 | -3.09 | -3.95 | -2.25 | -4.15 | Upgrade
|
Selling, General & Admin | 53.27 | 44.79 | 39.7 | 31.93 | 25.63 | 16.05 | Upgrade
|
Research & Development | 123.55 | 96.48 | 69.91 | 75.57 | 56.86 | 13.81 | Upgrade
|
Other Operating Expenses | -3.59 | -3.16 | -1.72 | -0.89 | 0.55 | -0.73 | Upgrade
|
Operating Expenses | 184.86 | 149.11 | 112.76 | 110.99 | 83.82 | 29.29 | Upgrade
|
Operating Income | -188.68 | -152.69 | -115.85 | -114.94 | -86.07 | -33.43 | Upgrade
|
Interest Expense | -1.63 | -0.01 | -0 | -0.25 | -0.45 | -0.53 | Upgrade
|
Interest & Investment Income | 8.05 | 3.75 | 1.05 | 0.07 | 0 | 0.5 | Upgrade
|
Earnings From Equity Investments | 9.67 | 6.12 | -4.96 | -3.24 | - | - | Upgrade
|
Currency Exchange Gain (Loss) | 0.12 | 0.12 | 3.68 | 8.19 | 2.15 | - | Upgrade
|
Other Non Operating Income (Expenses) | -0 | -0 | 0 | -0 | 0 | -0 | Upgrade
|
EBT Excluding Unusual Items | -172.47 | -142.71 | -116.07 | -110.17 | -84.37 | -33.47 | Upgrade
|
Gain (Loss) on Sale of Investments | -2.19 | -9.14 | - | 6.65 | 144.41 | - | Upgrade
|
Other Unusual Items | - | - | - | - | - | 43.17 | Upgrade
|
Pretax Income | -174.65 | -151.85 | -116.07 | -103.52 | 60.05 | 9.71 | Upgrade
|
Net Income | -174.65 | -151.85 | -116.07 | -103.52 | 60.05 | 9.71 | Upgrade
|
Net Income to Common | -174.65 | -151.85 | -116.07 | -103.52 | 60.05 | 9.71 | Upgrade
|
Net Income Growth | - | - | - | - | 518.46% | - | Upgrade
|
Shares Outstanding (Basic) | 103 | 95 | 78 | 77 | 70 | 69 | Upgrade
|
Shares Outstanding (Diluted) | 103 | 95 | 78 | 77 | 70 | 69 | Upgrade
|
Shares Change (YoY) | 14.01% | 20.98% | 2.29% | 9.65% | 0.90% | 5.81% | Upgrade
|
EPS (Basic) | -1.70 | -1.60 | -1.48 | -1.35 | 0.86 | 0.14 | Upgrade
|
EPS (Diluted) | -1.70 | -1.60 | -1.48 | -1.35 | 0.86 | 0.14 | Upgrade
|
EPS Growth | - | - | - | - | 512.92% | - | Upgrade
|
Free Cash Flow | -171.36 | -137.21 | -122.4 | -127.87 | -113.69 | 14.9 | Upgrade
|
Free Cash Flow Per Share | -1.66 | -1.45 | -1.56 | -1.67 | -1.63 | 0.21 | Upgrade
|
Operating Margin | -146263.57% | -117450.00% | -21217.22% | -25316.30% | -34020.55% | -9804.69% | Upgrade
|
Profit Margin | -135390.70% | -116807.69% | -21258.79% | -22801.10% | 23733.60% | 2847.21% | Upgrade
|
Free Cash Flow Margin | -132833.33% | -105543.08% | -22418.32% | -28165.42% | -44937.94% | 4369.80% | Upgrade
|
EBITDA | -182.35 | -147.11 | -110.98 | -110.55 | -85.29 | -33.29 | Upgrade
|
D&A For EBITDA | 6.33 | 5.58 | 4.87 | 4.38 | 0.78 | 0.15 | Upgrade
|
EBIT | -188.68 | -152.69 | -115.85 | -114.94 | -86.07 | -33.43 | Upgrade
|
Revenue as Reported | 5.51 | 4.36 | 3.75 | 2.58 | 0.44 | 44.3 | Upgrade
|
Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.